Earnings call transcript: Camil Alimentos faces revenue decline in Q4 2025

Camil Alimentos reported Q4 2025 net revenue of BRL 2.5 billion, down 16% year over year, as lower raw material prices pressured pricing, though EBITDA held flat at BRL 193 million and margin improved to 8.0% from 6.8%. Full-year revenue fell 9% to BRL 11.1 billion, while EBITDA rose to BRL 950 million with an 8.2% margin; shares dropped 9.36% after the release and the company highlighted growth in coffee, fish, and international volumes as key offsets.

Analysis

This is less a demand collapse than a pricing reset: unit growth held up while top-line compressed, which usually means the market is over-penalizing revenue optics and underestimating the earnings power of a deflationary input cycle. The key second-order effect is that lower commodity prices are simultaneously shrinking reported revenue and widening the gap between gross profit and cash earnings, creating a cleaner margin story into the next 1-2 quarters if volumes stay firm.

The real risk is not the quarter just reported, but whether the company can keep absorbing fixed costs if deflation persists and the mix shift toward lower-capacity categories stalls. The high-growth segments still appear underutilized, so incremental volume there should carry outsized margin leverage; conversely, if those categories fail to inflect, the company remains hostage to commodity pass-through and investor skepticism about sustainable growth.

Balance sheet flexibility is the swing variable for the next 6-12 months. Leverage is not distressed, but it is high enough that any disappointment in working capital or capex execution could force a slower capital return profile, which matters because the stock is already screening as a yield/value name. That creates a setup where the stock can de-rate again on a weak guide, but also rerate sharply on even modest evidence that volume growth is converting into cash flow rather than just defending margins.

Consensus is likely missing that this is a latent operating leverage story, not a simple commodity loser. If management can show that international and higher-margin branded categories keep growing while deflation lingers, reported revenue can stay soft even as equity value compounds through EBITDA and FCF. The market reaction looks directionally right for near-term sentiment, but potentially too aggressive if investors are treating nominal revenue as the core signal instead of mix, utilization, and cash conversion.

Key Decisions for Investors

• Initiate a tactical long in CAML3 on further post-earnings weakness, with a 3-6 month horizon; target a re-rating if next quarter confirms margin stability and volume growth, but size modestly given leverage and execution risk.
• Pair trade: long CAML3 / short a slower-growth Brazilian staple with tighter margins and less mix optionality, to isolate the deflation-benefit + utilization upside over the next 1-2 quarters.
• Sell downside via CAML3 cash-secured puts or put spreads into elevated post-earnings vol; the stock’s yield and valuation support should limit downside unless working capital or guidance deteriorates materially.
• If the market reopens the stock down another 5-10%, consider scaling in only after management commentary confirms high-growth segment utilization and no covenant pressure; avoid buying merely on headline P/E.
• For event-driven desks, wait for the next earnings call and look for a long catalyst if management quantifies capacity ramp in coffee/pasta/cookies; that would be the clearest signal that operating leverage is becoming visible.